Mitchell P Levesque
Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment
Diem S, Risch M, Recher M, Risch L, Dummer R, Levesque M, Mangana J, Hillmann D, Niederer R, Berner F, Ali O, Bomze D, Fässler M, Flatz L. Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment. J Immunother 2019; 42:89-93.
01.04.2019Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment
01.04.2019J Immunother 2019; 42:89-93
Diem Stefan, Risch Martin, Recher Mike, Risch Lorenz, Dummer Reinhard, Levesque Mitchell P, Mangana Joanna, Hillmann Dorothea, Niederer Rebekka, Berner Fiamma, Ali Omar Hasan, Bomze David, Fässler Mirjam, Flatz Lukas
Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients
Fässler M, Jörger M, Recher M, Risch L, Güsewell S, Risch M, Speiser D, Ludewig B, Levesque M, Dummer R, Siano M, Krolik M, Diem S, Mangana J, Hasan Ali O, Berner F, Bomze D, Ring S, Niederer R, Gil Cruz C, Pérez Shibayama C, Flatz L. Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients. J Immunother Cancer 2019; 7:50.
20.02.2019Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients
20.02.2019J Immunother Cancer 2019; 7:50
Fässler Mirjam, Jörger Markus, Recher Mike, Risch Lorenz, Güsewell Sabine, Risch Martin, Speiser Daniel E, Ludewig Burkhard, Levesque Mitchell P, Dummer Reinhard, Siano Marco, Krolik Michal, Diem Stefan, Mangana Joanna, Hasan Ali Omar, Berner Fiamma, Bomze David, Ring Sandra, Niederer Rebekka, Gil Cruz Cristina, Pérez Shibayama Christian Ivan, Flatz Lukas
IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells
Guenova E, Kaesler S, Thomas P, Mailhammer R, Ghoreschi K, Schäkel K, Amarov B, Eichner M, Schaller M, Clark R, Röcken M, Köberle M, Volz T, Levesque M, Skabytska Y, Hoetzenecker W, Weindl G, Sauer K, Tham M, Kim K, Park J, Seo J, Desislava I, Cozzio A, Biedermann T. IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells. Proc Natl Acad Sci USA 2015; 112:2163-8.
02.02.2015IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells
02.02.2015Proc Natl Acad Sci USA 2015; 112:2163-8
Guenova Emmanuella, Kaesler Susanne, Thomas Peter, Mailhammer Reinhard, Ghoreschi Kamran, Schäkel Knut, Amarov Boyko, Eichner Martin, Schaller Martin, Clark Rachael A, Röcken Martin, Köberle Martin, Volz Thomas, Levesque Mitchell P, Skabytska Yuliya, Hoetzenecker Wolfram, Weindl Günther, Sauer Karin, Tham Manuela, Kim Kyu-Won, Park Ji-Hyeon, Seo Ji Hae, Desislava Ignatova, Cozzio Antonio, Biedermann Tilo
Novel therapies for cutaneous T-cell lymphoma: what does the future hold?
Guenova E, Hoetzenecker W, Rozati S, Levesque M, Dummer R, Cozzio A. Novel therapies for cutaneous T-cell lymphoma: what does the future hold?. Expert Opin Investig Drugs 2014; 23:457-67.
08.01.2014Novel therapies for cutaneous T-cell lymphoma: what does the future hold?
08.01.2014Expert Opin Investig Drugs 2014; 23:457-67
Guenova Emmanuella, Hoetzenecker Wolfram, Rozati Sima, Levesque Mitchell P, Dummer Reinhard, Cozzio Antonio